Objectives-To estimate dermal absorption of vaporous and liquid 2-methoxyethanol (ME) and in volunteers. Methods-Five volunteers (two men and three women) were dermally exposed to vaporised and liquid ME and EE. Dermal exposure on an area of about 1000 cm2 (forearm and hand) to vapours ofME and EE (4000 mglm' ME and 3700 mglm' EE) lasted for 45 minutes. Duration of exposure to liquid ME and EE on an area of 27 cm2 (forearm) was 15 minutes. Dermal uptake was assessed by measurement of the main metabolites in urinary methoxyacetic acid (MAA) and ethoxyacetic acid (EAA). For each volunteer, excretion of metabolites was compared with a reference inhalatory exposure. Results-Mean (SD) absorption rates of ME and EE vapour were 36 (11) and 19 (6) cmlh respectively. The mean (SD) absorption rates of the liquid ME and EE amounted to 2-9 (2.0) and 0-7 (0.3) mglcm'.h. Conclusions-Vaporised and liquid ME and EE are readily absorbed through the skin. In the combined inhalatory and dermal exposure when whole body surface is exposed to vapour, the uptake through the skin is estimated to be 55% of the total uptake of ME and 42% of EE. Dermal uptake resulting from skin contact ofboth hands and forearms (about 2000 cm?) with liquid ME and EE for 60 minutes would exceed inhalatory uptake ofthe eight hour occupational exposure limit by 100 times at 16 mg/iM3 of ME and 20 times at 19 mg/mi of EE. The substantial skin uptake of ME and EE indicates that in assessing the health risks biological monitoring and use of biological exposure indices are preferable to environmental monitoring. (Occup Environ Med 1997;54:38-43) Keywords: 2-methoxyethanol; 2-ethoxyethanol, dermal exposure Although often comprising < 10% of the final product, 2-methoxyethanol (ME) and (4 7) hours.3
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Despite hard evidence that both glycol ethers as liquids are readily absorbed through human skin in vitro7 there are few human data on skin absorption of ME and EE in the liquid as well as in the vapour phase. Human data for skin uptake of another glycol ether 2-butoxyethanol have been published,8 9 reporting that dermal exposure to 2-butoxyethanol, both liquid and vapour, was even more important than respiratory uptake. The purpose of this study was, therefore, to estimate the percutaneous absorption of ME and EE in volunteers under controlled experimental conditions.
Subjects and methods

SUBJECTS
The volunteers (two men and three women) ranged in age from 22 to 25. All were without a history of serious diseases and their skins appeared normal. None of them took medicines or alcohol from at least 12 hours before exposure until the end of collection of urine. The experimental protocol was submitted to and approved by the medical ethics committee of the Academic Medical Center, University of Amsterdam. An informed consent form was signed by each subject.
Given the very long half life of MAA (74 hours)4 and of EAA (44 hours),3 the period between the two exposures in each volunteer was at least three weeks.
GENERATION OF GLYCOL ETHER VAPOUR
Medical air at a flow rate of about 3 1/min Coronel Laboratorium, from a compressed air cylinder was led through a bottle filled with neat ME or EE. The vapour stream was led through teflon tubes into and out of the exposure cylinder.
EXPERIMENTAL SETTING
Dermal exposure to vapour and liquid The volunteer was situated in a clean air cabin with a slightly increased pressure to avoid additional inhalatory exposure. The exposure lasted for 45 minutes. The arm of the subject was the only part of the body outside the cabin. During the vapour exposure experiments, the subject placed the lower arm into the exposure cylinder into which the glycol ether vapour was led. The exposure cylinder (volume 6-5 1) was provided with one large opening for the forearm and five small openings of about 3 mm internal diameter: two inlets, two outlets, and an opening for the vapour sampling. The vapour concentrations of ME and EE were about 10 times below the saturation concentration. To minimise the influence of temperature and humidity in the cylinder on the skin absorption and to prevent condensation on the skin, the flow of ME and EE of about 31/min was used. The temperature varied from 220C to 250C and the relative humidity from 60% to 65%. To avoid contamination of inhaled air through leakage, the opening in the cylinder and on the cabin were provided with cuffs. The concentrations of ME and EE in the cylinder were measured every five minutes throughout exposure.
During exposure to liquid ME and EE, a glass chamber with an area of 27 cm2 was placed on the volar forearm and filled with ME or EE. After 15 minutes the exposure vessel was removed and the remaining solvent gently wiped off with a tissue. At the end of exposure the subject stayed for another 15 minutes in the cabin to allow the glycol ether to evaporate from the skin surface and to prevent possible inhalatory uptake.
Inhalatory exposure Each volunteer was exposed during four periods of 15 minutes to a concentration of about three times the current OEL value in The Netherlands (16 and 19 mg/M3 for ME and EE respectively). The time between the exposures was 10 minutes. Volunteers were in a sitting position and inhaled through a mouthpiece with a one way valve connected to a Tedlar (DuPont, Delaware, USA) bag containing ME and EE. During exposure the total amount of exhaled air was collected in another Tedlar bag. To prevent condensation of water in the exhaled air bag, a cold water trap (held at 0C) was placed between the mouthpiece and exhaled air bag. To correct for the amount of ME and EE possibly absorbed in the water trap, we measured the amount of ME and EE absorbed in the condensate in the cold trap after consecutive 15 minute exposures of four subjects; this amount was taken into account when calculating the respiratory uptake. To determine the actual exposure concentration, air samples were taken from the inhalation bag before and during exposure from a point situated in the system before the mouthpiece.
Urine collection All urine was collected for the first two days; for practical reasons, on days three to five only a morning and last evening sample were taken. One person collected all urine for seven days. For each sample, volume, creatinine, and specific gravity were measured and the samples were stored at -20'C until analysis.
Analysis
Analysis of inhaled and exhaled air was performed by gas chromatography. Air samples were injected with gas tight syringes into a gas chromatograph.
The MAA and EAA in urine were measured by a slightly modified version of the method of
To 100 u1 urine 25 yul butoxyacetic acid (20 mg/l)(internal standard) and 100 ,ul phosphate buffer (pH = 7) were added. Thereafter, samples were left at 60°C under slightly reduced pressure (20 mm Hg) to evaporate to dryness (about 20 minutes). After cooling down to room temperature 500 Ml 5% derivatisation reagent (2,3,4,5,6-pentafluorobenzyl bromide) (Aldrich Chemie, Germany) in methanol was added. Derivatisation was allowed to proceed for three hours at 70°C; after cooling down to room temperature, 500 jl water was added then 500 Ml n-hexane. Samples were vortexed for one minute and then centrifuged for two minutes at 3000 g. One MI hexane extract was injected into the gas chromatograph. Under these conditions, the detection limit of the method was 10 g/1 for both MAA and EAA.
Gas chromatographic conditions for the analysis of metabolites in urine The gas chromatograph used was a Hewlett Packard Model 5890 A, equipped with an electron capture detector and a CP-SIL-1 3CB column (25 m; 0-25 mm internal diameter; film thickness 0-2 Mm) ( follows: the subject put on a rubber glove which fitted as well as possible without stretching on the hand. The area was then assessed by comparing the weights of the glove and of a piece of glove of a known area.
Calculation of uptake
The respiratory uptake (UiJ,,) and dermal uptake (Udw,vap and Uder,liq) of ME and EE was calculated from the equations (1) and (2):
Uinh (mg) = (cinh -ceD) X V (1) where cin, = concentration ME or EE in inhaled air bag; Ceh= concentration in exhaled air bag (corrected for the amount absorbed in the water trap); V = volume inhaled ( = exhaled) air; and Uder(mg) = (MAA(EAA)der,48h/ MAA(EAA)inh,48 h) X Uinh (2) where MAA(EAA)der,48 h = amount of excreted MAA(EAA) in urine during the 48 hours after Permeability parameters Exposure to vapour-The absorbtion rate (cm/h) was calculated by dividing the absorbed amount of ME and EE (Uder,vap) (mg) by the exposed area (cm2), the duration of exposure (h), and the exposure concentration (mg/cm3).
Exposure to liquid-The dermal penetration rate (dermal flux) (mg/cm2.h) was calculated by dividing the total absorbed amount (Uder,iq)(mg), by the skin exposure area (cm2) and the exposure duration (h).
Results Table 1 shows the experimental conditions of inhalatory exposure to ME and EE. For each volunteer, the calculated respiratory uptake (Uinh) of ME and EE and the 48 hour cumulative excretion of the corresponding acid metabolite are presented along with the respiratory uptake and retention defined as (CiGh -C,,,h)/CG) x 100%.
Estimation of dermal uptake of vaporised and liquid ME and EE was based on the 48 hour MAA and EAA urinary excretion, MAA(EAA)der,48 h. Tables 2 and 3 show the amounts absorbed dermally and calculated on an individual basis by comparison with a reference inhalatory exposure and exposure conditions. Tables 2 and 3 also show the permeability parameters for MA and EA vapour (absorbtion rate, cm/h) and for liquid (absorption rate, mg/cm2.h). The results indicate that ME vapour penetrated the skin faster then EE; the absorbtion rate for ME amounted to 36 cm/h and to 19 cm/h for EE (table 2) . The difference in penetration between ME and EE is even more pronounced after exposure to liquid; the absorption rate amounted to 2-9 for ME and 07 mg/cm2.h for EE (table 3). To compare dermal uptake of liquid ME and EE with inhalatory uptake, we extrapolated the uptake determined in our study (exposed area of 27 cm2 and exposure duration of 15 minutes) to a skin area of 2000 cm2 (both forearms and hands) and exposure duration of 60 minutes. The use of inhalatory exposure as reference is based on the assumption that the toxicokinetics of ME and EE once absorbed in the systemic circulation is identical for both exposure routes. The excretion of both metabolites showed a similar pattern independent of expo- Figure 3 Urinary excretion ofMAA after dermal exposure to vaporised ME. sure route: an initially fast increase in the concentration then slow and highly irregular excretion (figs 1-3). Before exposure neither MAA nor EAA was present in the urine in concentrations exceeding the detection limit of the analytical method (0-01 mg/l). The mean (SD) elimination half life calculated from the slope of the log linear excretion time curve 72 (24) hours for MAA and 44 (8) The long half life of MAA and EAA and a circadian excretion pattern could probably be explained by protein binding of MAA and EAA in blood or their reabsorption in the kidneys. Binding to proteins and elimination by saturable kinetics in the kidneys were reported by Corely and Bormett"2 for butoxyacetic acid (BAA), a compound with a comparable chemical structure to MAA and EAA. A similar urinary excretion pattern, with a circadian variation and a long half life, was also reported by Monster et all' for trichloroacetic acid, a metabolite of trichloroethylene. Circadian excretion rhythm is important if MAA and EAA are used as generally accepted biological exposure indices. A consistent sampling time has, therefore, to be applied.
Respiratory retention of both ME and EE was high, about 80%, as could be expected from the very high blood/air partition coefficients of 32 836 and 22 093 for ME and EE, respectively.'4 Respiratory retentions estimated in our study were somewhat higher than the values of 76% and 64% for ME and EE reported by Groesenken et al.34 These differences could be explained by different exposure conditions (mouth only in our study versus nose and mouth exposure in the studies of Groesenken et al. 3 4 This study showed that vaporised and liquid ME and EE are readily absorbed through the skin. The absorbtion rates into the skin normalised by cocentration of ME vapour is 36 cm/h and 19 cm/h for EE. Higher absorption of ME was more pronounced in exposure to liquid where an absorption rate of 2-9 for ME and 0-7 mg/cm2.h for EE was estimated. Theoretically, the same ratio in permeability of ME and EE could be expected in exposure both to liquid and vapour. However, a high variation between people in both permeability parameters precludes speculation about the source of this discrepancy. Dugard and Walker7 reported that liquid ME has a higher skin damage ratio than EE. This could possibly affect the skin integrity, and consequently increase the absorption of ME, in relation to EE. The absorption rate of liquid ME and EE estimated in our study is in close agreement with findings reported from the in vitro studies of Dugard and Walker7 who reported mean (SD) values of 2-82 (2-63) for ME and 0-796 (0 46) mg/cm2.h for EE.
In risk assessment it is important to estimate the relevance of skin uptake in relation to the other exposure routes. Inhalation exposure is assumed to be the most important uptake route for most organic solvents. However, ME and EE penetrate the skin so easily that skin contact of both hands and forearms (about 2000 cm2) with liquid for one hour, greatly exceeds the respiratory uptake at OEL for eight hours (ME 100-fold and EE 20-fold).
The question arises as to how realistic is such extensive skin contact with liquid ME and EE in occupational settings. It has to be stressed, however, that if spilling of ME and EE on clothing occurs, an even higher exposed area and exposure time can be expected. This exposure scenario (2000 cm2 exposure area for one hour) was proposed by the ECETOCG" as a criterion for assigning a skin notation. According to that criterion, a skin notation should be given if the dermal uptake under these conditions amounted to > 10% of the inhalatory uptake.
Dermal absorption of vapours is generally considered to be of minor importance compared with pulmonary uptake. However, it should be realised that a whole body skin area of 1-8 m2 confronted with a mean air velocity of 2 km/h was swept by a volume of 28 800 m3 in eight hours,'5 considerably more than the corresponding inhaled volume of 10 m3. On the other hand, difference in the relative surface areas (1*8 m2 for the skin v 30-100 m2 for the lungs),'6 percentages of the cardiac output (100% for the lungs v 3% for the skin), and the distance that the compound must penetrate to reach the blood favour the lungs, generally speaking, as the primary site of absorption in a whole body exposure. However, our study shows that the skin is a significant uptake route for ME and EE vapour. If we assume whole body dermal and inhalatory exposure to vapour, the contribution of the skin to the total uptake would amount to 55% for ME and 42% for EE. Of course, this approach is simplified and some assumptions have been used in making these calculations. Firstly, that skin penetration characteristics of the forearms and hands (about 10 % of the total body area) are representative for the whole body, and secondly that clothing and possibly higher temperature and humidity under the clothing does not notably affect skin penetration. It is well known, however, from several experimental studies, that these factors could have an impact on the skin permeability.'7 Previously, Johanson and Boman8 reported that dermal uptake of butoxyethanol accounts for about 75% of the total uptake during whole body exposure to butoxyethanol vapour with a tendency towards increased percutaneous absorption rate under conditions of increased temperature and humidity (33°C, 71% relative humidity in comparison with 23°C and 29% relative humidity) although the differences were not significant. However, with physiologically based pharmacokinetics models, Corely and Bormett"2 estimated the contribution of dermal uptake to be 21% of the total uptake, pointing out that the dermal uptake of butoxyethanol in the study of Johanson and Boman8 was overestimated due to the method of calculating uptake. The contribution of 21% would be more consistent with the assumption that permeability of homologous glycol ethers decreases with the number of C atoms in the chain, as found in the present study and in the study of Dugard and Walker.7 Applying another mathematical model from the literature,'8 based on the octanol/water partition coefficient, molecular weight and vapour pressures, we estimated contribution of whole body dermal uptake to be 32%, 40%, and 61% of the total uptake for ME, EE, and BE, respectively. Although these values are of the same order of magnitude as our results, the permeability coefficient calculated with this model seems to increase with the number of C atoms and thus contrasts with our results and the in vitro study reported by Dugard and Walker.7 In summary, results of the present study show that dermal absorption associated with exposure to ME and EE vapour and liquid is of major importance. In the mixed inhalatory and dermal exposure when the whole body surface is exposed to vapour, dermal uptake would contribute 55% of the total uptake for ME and 42% for EE. Skin contact of both hands and forearms for 15 minutes with liquid ME and EE would considerably exceed the eight hour inhalatory uptake at the OEL. In monitoring exposure at the workplace, substantial skin uptake of ME and EE indicates that biological monitoring is to be preferred over environmental monitoring.
Also, the experimental set up used in the present study proved to be suitable for measurement of dermal absorption of chemical vapours and liquids in humans, providing the necessary data for the assessment of the health risks of exposure to these solvents.
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